PTPN11 and cancer: Furthermore, for patients undergoing ICI therapy as part of cancer treatment, cardiovascular monitoring may yield valuable opportunities for detection along with preservation strategies to preserve endothelial SHP2 signaling to mitigate long-term vascular adverse events.